On a reported basis, revenue rose from KRW 4.07 billion in 2022 to KRW 5.58 billion in 2023, up 36.8% year on year, which was the largest year of 2022 to 2025. It fell to KRW 3.47 billion in 2024, down 37.8% year on year and the smallest year, and recovered slightly to KRW 3.69 billion in 2025, up 6.5% year on year.
Operating losses were KRW 33.2 billion in 2022, KRW 32.1 billion in 2023, KRW 34.2 billion in 2024 and KRW 24.8 billion in 2025, which is four consecutive years of losses. The loss narrowed in 2023, widened in 2024 when revenue fell, and narrowed again in 2025.
Operating margins were -815.6% in 2022, -575.0% in 2023, -987.8% in 2024 and -671.2% in 2025, so the ratio was most negative in the year revenue was smallest.
Net loss attributable to controlling shareholders was KRW 34.9 billion in 2022, KRW 22.9 billion in 2023, KRW 32.8 billion in 2024 and KRW 24 billion in 2025, and net loss including non-controlling interests was reported at the same yearly amounts.
Operating cash flow was negative in every year, at -KRW 21 billion in 2022, -KRW 24.9 billion in 2023, -KRW 27.8 billion in 2024 and -KRW 23.4 billion in 2025. The debt-to-equity ratio moved from 84.0% in 2022 to 27.5% in 2023, 28.1% in 2024 and 34.9% in 2025.
Total equity at the end of 2025 was KRW 53.6 billion, all attributable to controlling shareholders, against total liabilities of KRW 18.7 billion.
By quarter, revenue jumped to KRW 1.26 billion in the fourth quarter of 2025, up 70.5% from the prior quarter, then fell to KRW 783 million in the first quarter of 2026, rose to KRW 898 million in the second quarter and was KRW 863 million in the third quarter.
The operating loss widened from KRW 6.08 billion in the third quarter of 2025 to KRW 6.4 billion in the second quarter of 2026 before narrowing to KRW 4.93 billion in the third quarter.
Net loss attributable to controlling shareholders over the last four quarters, from the fourth quarter of 2025 to the third quarter of 2026, totaled KRW 21.3 billion.
A 2024 press report put ordinary R&D spending at KRW 18.9 billion in 2022 and KRW 22.5 billion in 2023, with KRW 15.6 billion spent through the third quarter of 2024, so a large share of the losses is tied to pipeline research.